In vitro studies of intrinsic cellular radiosensitivity following 4 MeV photons or 62.5 MeV (p-->Be+) neutrons. Potential implications for high LET therapy.

Recent studies of the intrinsic cellular sensitivity of 30 human in vitro cell lines to 4 MeV photons and 62.5 MeV (p-->Be+) neutrons have identified relatively neutron sensitive cell lines with high alpha values within the more resistant end of the photon radiation response range. Here we present data comparing the surviving fraction at 2 Gy of photons (SF2) to the surviving fractions at 1.6, 0.85 and 0.6 Gy of neutrons respectively (SF1.6 SF0.85 and SF0.6). With the ratio SF2/SF1.6 a negative trend can be seen between the probability of a preferential response to neutrons and relative photon resistance. With a ratio of SF2/SF0.6, however, a highly significant benefit for 62.5 MeV neutrons can be seen in the more photon resistant lines. We suggest further clinical studies to explore the potential relevance of these in vitro findings to the clinical situation should be undertaken.

[1]  H. Warenius,et al.  Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons. , 1994, International journal of radiation oncology, biology, physics.

[2]  H. Warenius,et al.  C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance. , 1994, European journal of cancer.

[3]  H. Warenius,et al.  The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  H. Warenius,et al.  The inherent cellular sensitivity to 62.5 MeV(p----Be+) neutrons of human cells differing in photon sensitivity. , 1992, International journal of radiation biology.

[5]  A. Wambersie,et al.  The Role of Microdosimetry in Radiotherapy , 1990 .

[6]  A Wambersie,et al.  Review of the clinical results of fast neutron therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  M. Zaider,et al.  Changes in biological effectiveness of the neutron beam at Clatterbridge (62 MeV p on Be) measured with cells in vitro. , 1989, The British journal of radiology.

[8]  T. Pajak,et al.  Neutron vs photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC Cooperative Randomized Study. , 1988, International journal of radiation oncology, biology, physics.

[9]  F. W. Bauer,et al.  A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation. , 1988, Cytometry.

[10]  D. Shrieve,et al.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. , 1985, Cytometry.

[11]  G. Laramore,et al.  Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study. , 1985, International journal of radiation oncology, biology, physics.

[12]  G. Steel,et al.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  P. Deschavanne,et al.  In vitro radiosensitivity of six human cell lines. II. Relation to the RBE of 50-MeV neutrons. , 1982, Radiation research.

[14]  J. Battermann,et al.  Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays. , 1981, European journal of cancer.

[15]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Thames,et al.  The Response of Chinese Hamster Ovary Cells to Fast Neutron Radiotherapy Beams: III. Variation in Relative Biological Effectiveness with Position in the Cell Cycle , 1978 .

[17]  J. J. Broerse,et al.  Differences in radiosensitivity of cells from various types of experimental tumors in relation to the RBE of MeV neutrons. , 1977, International journal of radiation oncology, biology, physics.

[18]  V. Courtenay,et al.  In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft , 1976, Nature.

[19]  M. Friedman,et al.  Population distribution in tumors and normal tissues: a guide to tissue radiosensitivity , 1974 .

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  J. Fowler,et al.  Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. I. The biological and physical advantages and problems of neutron therapy. , 1963, The British journal of radiology.

[22]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.